AfliberceptQualityChecker

Aflibercept

API assay biologics biosimilars endotoxins fixed-dose combinations generics impurities
Open selection
Aflibercept Quality Checker — Biologic Drug (Recombinant Fusion Protein) (Ph. Eur., USP, ICH Q6B)

ℹ️  The utility checks aggregates, oxidation, deamidation, HCP, DNA, subvisible particles, sterility.
ℹ️  Does not use machine learning — rule-based logic only.
⚠️  CRITICAL! Aggregates ≤1%, HCP ≤100 ppm, DNA ≤10 ng/mL, sterility (intravitreal injection)!

Usage:
  AfliberceptQualityChecker.exe                            → demo mode
  AfliberceptQualityChecker.exe input.csv output.json      → evaluate data

Input format:
BatchNumber,Protein_Concentration_mgPerMl,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Main_Peak_Percent_IEC,Oxidation_Percent,Deamidation_Percent,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Protein_A_Leaching_ngPerMl,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,SterilityTest,Endotoxin_EU_ml,Potency_Relative_Percent

Example:
AFL-BIO-2026-001,40.2,6.2,290,0.3,0.2,20.0,10.0,70.0,0.8,2.5,35,1.5,0.8,2500,300,10,0,0.02,95.0

— WHY IS THIS NEEDED?
Aflibercept — recombinant chimeric fusion protein (VEGF receptor trap), administered intravitreally (eye injection):
• Aggregates (HMW): Critical safety parameter. Aggregates can cause intraocular inflammation or immune response. Limit is strict (≤1%).
• Post-Translational Modifications (PTMs): Oxidation and deamidation affect VEGF binding activity. Strictly controlled.
• Charge Variants (IEC): Show molecule heterogeneity (sialic acids, C-terminal lysines).
• Process Impurities: HCP (CHO cell protein) and DNA must be removed to trace levels.
• Subvisible Particles: For ophthalmic products, particle requirements are especially strict due to risk of retinal vessel occlusion.
• Potency: Biological activity (VEGF binding) must be within 70-130%.
⚠️ CRITICAL:
• Aggregates ≤ 1.0% (SEC-HPLC) — exceedance leads to batch recall.
• HCP ≤ 100 ppm — residual protein can be toxic to retina.
• DNA ≤ 10 ng/mL — risk of genomic integration in eye cells.
• Sterility and Endotoxins — absolutely mandatory. Endotoxin limit for intravitreal injections is extremely low.
• Particles >25 µm ≤ 60 counts/mL — USP <788> standard.
⚠️ Note: Utility accounts for specifics of ophthalmic biologics. Special attention to oxidation (Met/Trp) and deamidation (Asn), as these PTMs rapidly reduce drug activity. Check includes data from SEC, IEC, HIC, ELISA (HCP, Protein A), and particle counting. Any deviation in sterility or aggregates is critical.

input.csv

BatchNumber,Protein_Concentration_mgPerMl,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Main_Peak_Percent_IEC,Oxidation_Percent,Deamidation_Percent,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Protein_A_Leaching_ngPerMl,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,SterilityTest,Endotoxin_EU_ml,Potency_Relative_Percent
AFL-BIO-2026-001,40.2,6.2,290,0.3,0.2,20.0,10.0,70.0,0.8,2.5,35,1.5,0.8,2500,300,10,0,0.02,95.0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: AfliberceptQualityCheckerAPI / object: AfliberceptCategory: Global API

1. Scope

The Aflibercept Quality Checker utility is used for Aflibercept. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API

Tags: API, assay, biologics, biosimilars, endotoxins, fixed-dose combinations, generics, impurities, injectables, market map, sterility

2. Execution modes

AfliberceptQualityChecker.exe                            → demo mode
AfliberceptQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • microbiology and pathogens
  • pH and physicochemical parameters

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! Aggregates ≤1%, HCP ≤100 ppm, DNA ≤10 ng/mL, sterility (intravitreal injection)!
  • Aggregates (HMW): Critical safety parameter. Aggregates can cause intraocular inflammation or immune response. Limit is strict (≤1%).
  • ⚠️ CRITICAL:
  • Aggregates ≤ 1.0% (SEC-HPLC) — exceedance leads to batch recall.
  • HCP ≤ 100 ppm — residual protein can be toxic to retina.
  • DNA ≤ 10 ng/mL — risk of genomic integration in eye cells.
  • Sterility and Endotoxins — absolutely mandatory. Endotoxin limit for intravitreal injections is extremely low.
  • Particles >25 µm ≤ 60 counts/mL — USP <788> standard.
  • ⚠️ Note: Utility accounts for specifics of ophthalmic biologics. Special attention to oxidation (Met/Trp) and deamidation (Asn), as these PTMs rapidly reduce drug activity. Check includes data from SEC, IEC, HIC, ELISA (HCP, Protein A), and particle counting. Any deviation in sterility or aggregates is critical.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Aflibercept with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, microbiology and pathogens, pH and physicochemical parameters.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberAFL-BIO-2026-001mandatory field; used for batch/lot traceability
2Protein_Concentration_mgPerMldecimalmg/mlProtein Concentration mg per Ml40.2numeric value; compared with assay/purity limit from specification or method
3pH_ValuedecimalpHp H Value6.2mandatory numeric value; rule comparison is performed by the utility
4Osmolality_mOsm_kgdecimalmOsm/kgOsmolality m Osm kg290mandatory numeric value; rule comparison is performed by the utility
5Aggregate_Percent_SECdecimal%Aggregate % SEC0.3mandatory numeric value; rule comparison is performed by the utility
6Fragment_Percent_SECdecimal%Fragment % SEC0.2mandatory numeric value; rule comparison is performed by the utility
7Acidic_Variants_Percent_IECdecimal%Acidic Variants % IEC20.0mandatory numeric value; rule comparison is performed by the utility
8Basic_Variants_Percent_IECdecimal%Basic Variants % IEC10.0mandatory numeric value; rule comparison is performed by the utility
9Main_Peak_Percent_IECdecimal%Main Peak % IEC70.0mandatory numeric value; rule comparison is performed by the utility
10Oxidation_Percentdecimal%Oxidation %0.8mandatory numeric value; rule comparison is performed by the utility
11Deamidation_Percentdecimal%Deamidation %2.5mandatory numeric value; rule comparison is performed by the utility
12Host_Cell_Protein_ppmdecimalppmHost Cell Protein ppm35mandatory numeric value; rule comparison is performed by the utility
13Residual_DNA_ngPerMldecimalas specifiedResidual DNA ng per Ml1.5mandatory numeric value; rule comparison is performed by the utility
14Protein_A_Leaching_ngPerMldecimalas specifiedProtein A Leaching ng per Ml0.8mandatory numeric value; rule comparison is performed by the utility
15Subvisible_Particles_2_10_umdecimalµmSubvisible Particles 2 10 um2500mandatory numeric value; rule comparison is performed by the utility
16Subvisible_Particles_10_25_umdecimalµmSubvisible Particles 10 25 um300mandatory numeric value; rule comparison is performed by the utility
17Subvisible_Particles_gt_25_umdecimalµmSubvisible Particles gt 25 um10mandatory numeric value; rule comparison is performed by the utility
18SterilityTestboolean / flag0/1Sterility Test0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
19Endotoxin_EU_mldecimalas specifiedEndotoxin EU ml0.02numeric value; critical safety attribute compared with endotoxin limit
20Potency_Relative_Percentdecimal%Potency Relative %95.0mandatory numeric value; rule comparison is performed by the utility

CSV example

BatchNumber,Protein_Concentration_mgPerMl,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Main_Peak_Percent_IEC,Oxidation_Percent,Deamidation_Percent,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Protein_A_Leaching_ngPerMl,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,SterilityTest,Endotoxin_EU_ml,Potency_Relative_Percent
AFL-BIO-2026-001,40.2,6.2,290,0.3,0.2,20.0,10.0,70.0,0.8,2.5,35,1.5,0.8,2500,300,10,0,0.02,95.0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable AfliberceptQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Aflibercept, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "AfliberceptQualityChecker",
  "api": "Aflibercept",
  "batchNumber": "AFL-BIO-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "AFL-BIO-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Protein_Concentration_mgPerMl",
      "value": "40.2",
      "unit": "mg/ml",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH_Value",
      "value": "6.2",
      "unit": "pH",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Osmolality_mOsm_kg",
      "value": "290",
      "unit": "mOsm/kg",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Aggregate_Percent_SEC",
      "value": "0.3",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Fragment_Percent_SEC",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Acidic_Variants_Percent_IEC",
      "value": "20.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Basic_Variants_Percent_IEC",
      "value": "10.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Biopharmaceuticals Core QC Suite

Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.

Open

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Global API & Biosimilars QC Suite

Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.

Open

Immunology QC Suite

QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Ophthalmology QC Suite

QC package for ophthalmology: eye drops, antiglaucoma agents, antibiotics, sterile solutions, osmolality, pH, particles and preservatives.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open